Skip to main content
Zeynep Eroglu, MD, Oncology, Tampa, FL

ZeynepErogluMD

Oncology Tampa, FL

Physician

Overview of Dr. Eroglu

Dr. Zeynep Eroglu is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. She received her medical degree from David Geffen School of Medicine at UCLA and has been in practice 9 years. She is one of 170 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. She has more than 90 publications and over 500 citings.

Education & Training

  • Los Angeles County-Harbor-UCLA Medical Center 1
    Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 2012 - 2015
  • University of California (Irvine)
    University of California (Irvine)Residency, Internal Medicine, 2008 - 2011
  • David Geffen School of Medicine at UCLA
    David Geffen School of Medicine at UCLAClass of 2008

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2025
  • FL State Medical License
    FL State Medical License 2015 - 2025
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-cell Populations  
    Zeynep Eroglu, Iman Osman, Theodore S Nowicki, Antoni Ribas, Michael A Davies, Farbod Darvishian, Daniel Y Wang, Douglas B Johnson, Ravi K Amaravadi, Clinical Cancer Research

Lectures

  • Phase I study of vemurafenib (VEM) and cobimetinib (COB) with heat shock protein 90 (HSP90) inhibitor XL888 in advanced BRAFV600 mutant melanoma. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Retrospective analysis of patients with sentinel lymph node (SLN) positive melanoma (MEL) who received adjuvant nivolumab (NIVO) without completion lymph node dissecti... 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Desmoplastic Melanoma Highly Responsive to Immunotherapy
    Desmoplastic Melanoma Highly Responsive to ImmunotherapyMay 11th, 2023
  • Desmoplastic Melanoma Responds to Pembrolizumb Monotherapy
    Desmoplastic Melanoma Responds to Pembrolizumb MonotherapyApril 20th, 2023
  • Woman's Breast Tumor Turned Out to Be Melanoma. But There Was Never a Mole
    Woman's Breast Tumor Turned Out to Be Melanoma. But There Was Never a MoleMarch 13th, 2021
  • Join now to see all